This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
healthcare: Archive
AI, Cancer Vaccines, and Next-Gen Medicine
by Neena Mishra
Could cancer vaccines and AI drive the next wave of healthcare innovation?
MRNANegative Net Change HLTHNegative Net Change CANCNegative Net Change
healthcare
UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?
by Kaibalya Pravo Dey
UNH's 39% six-month rally reflects improving medical costs, stronger earnings estimates and a sharper focus on profitable businesses.
UNHPositive Net Change HUMPositive Net Change ELVPositive Net Change
healthcare hmo insurance medical
Centene Stock Roars Back 117% in a Year: Is CNC Still a Buy?
by Kaibalya Pravo Dey
CNC's 117% rally now has support from improving margins, firmer pricing and higher earnings expectations, while valuation remains below key peers.
CNCPositive Net Change UNHPositive Net Change ELVPositive Net Change
healthcare hmo insurance medical
Oscar Health Skyrockets 109% YTD: Time to Bet on the Stock Now?
by Tanuka De
Oscar Health has surged 109% YTD as membership, revenue and expansion plans strengthen, though its price-to-book multiple tops the industry average.
OSCRPositive Net Change MOHPositive Net Change CNCPositive Net Change
healthcare hmo insurance
UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?
by Rajshree Sipani
UNH outpaces ELV with stronger earnings prospects, improving Medicare profitability, greater upside and a more favorable risk-reward profile.
UNHPositive Net Change ELVPositive Net Change
artificial-intelligence automation dividend-yield earnings-outlook earnings-surprise healthcare hmo hospitals insurance oncology-screening smart-health
UnitedHealth Stock Looks Reasonable at 18.39X P/E: Should You Buy Now?
by Kaibalya Pravo Dey
UNH's improving medical costs, higher EPS estimates and capital returns support its recovery, but regulatory risks remain.
UNHPositive Net Change HUMPositive Net Change ELVPositive Net Change
healthcare hmo insurance medical
Leading Women-Run Companies Shaping the Future of Business
by Shrabana Mukherjee
CNC, DAR, GD, FCEL and CC stocks show how women-led companies are redefining growth with discipline, agility and results.
GDPositive Net Change DARPositive Net Change CNCPositive Net Change FCELNegative Net Change CCPositive Net Change
energy finance healthcare thematic
CVS Q2 Earnings Call Pairs Aetna Recovery With 2027 PBM Risks
by Zacks Equity Research
CVS Health lifts its 2026 outlook on Aetna's recovery and retail strength while flagging 2027 pressure from 340B changes and Caremark membership declines.
CVSPositive Net Change
earnings healthcare
UnitedHealth vs. Centene: Which Managed Care Stock Is the Better Buy?
by Rajshree Sipani
UNH's diversified platform, AI expansion and Optum momentum strengthen its long-term outlook, making it the stronger managed care pick over CNC.
UNHPositive Net Change CNCPositive Net Change
artificial-intelligence automation cancer healthcare hmo hospitals insurance insurance-premium medical pharmaceuticals smart-health staffing
UnitedHealth's Cost-Control Story is Gaining Momentum: Time to Buy?
by Kaibalya Pravo Dey
UNH's improving cost control, lower medical costs and higher 2026 outlook are boosting confidence as its profitability recovery gains traction.
UNHPositive Net Change MOHPositive Net Change CNCPositive Net Change
earnings-report earnings-surprise healthcare hmo insurance medical